bluebird bio, Inc. Operating Lease Cost
bluebird bio, Inc. reported Operating Lease Cost of $6.93 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2025-05-14
- bluebird bio, Inc. operating lease, cost for the quarter ending 2025-03-31 was $6.93M, a 26.89% decline year-over-year.
- bluebird bio, Inc. operating lease, cost for the quarter ending 2024-12-31 was $9.49M, a 7.10% increase year-over-year.
- bluebird bio, Inc. operating lease, cost for the quarter ending 2024-09-30 was $9.49M, a 17.30% decline year-over-year.
- bluebird bio, Inc. operating lease, cost for the quarter ending 2024-06-30 was $9.49M, a 17.30% decline year-over-year.
- bluebird bio, Inc. operating lease, cost for fiscal 2024 was $37.95M, a 12.30% decline from fiscal 2023.
- bluebird bio, Inc. operating lease, cost for fiscal 2023 was $43.27M, a 19.79% increase from fiscal 2022.
- bluebird bio, Inc. operating lease, cost for fiscal 2022 was $36.12M, a 44.10% increase from fiscal 2021.
- bluebird bio, Inc. operating lease, cost for fiscal 2021 was $25.07M, a 34.34% increase from fiscal 2020.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed | Operating Lease, Cost 842 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | $6.93M 10-Q · filed 2025-05-14 | $16.43M derived: sum of 2 quarters · filed 2025-05-14 | $25.91M derived: sum of 3 quarters · filed 2025-05-14 | $35.40M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | $9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $18.98M derived: sum of 2 quarters · filed 2025-03-27 | $28.46M derived: sum of 3 quarters · filed 2025-03-27 | $37.95M 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $9.49M 10-Q · filed 2024-11-14 | $18.97M derived: sum of 2 quarters · filed 2024-11-14 | $28.46M 10-Q · filed 2024-11-14 | $37.32M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-06-30 | $9.49M 10-Q · filed 2024-09-27 | $18.97M 10-Q · filed 2024-09-27 | $27.83M derived: sum of 3 quarters · filed 2025-05-14 | $39.30M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-03-31 | $9.49M 10-Q · filed 2025-05-14 | $18.35M derived: sum of 2 quarters · filed 2025-05-14 | $29.82M derived: sum of 3 quarters · filed 2025-05-14 | $41.29M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $20.33M derived: sum of 2 quarters · filed 2025-03-27 | $31.80M derived: sum of 3 quarters · filed 2025-03-27 | $43.27M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $11.47M 10-Q · filed 2024-11-14 | $22.94M derived: sum of 2 quarters · filed 2024-11-14 | $34.41M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $11.47M 10-Q · filed 2024-09-27 | $22.94M 10-Q · filed 2024-09-27 | ||||
| 2023-03-31 | $11.47M 10-Q · filed 2024-09-13 | |||||
| 2022-12-31 | $36.12M 10-K · filed 2024-09-13 | $56.10M 10-K · filed 2023-03-29 | ||||
| 2021-12-31 | $25.07M 10-K · filed 2023-03-29 | |||||
| 2020-12-31 | $18.66M 10-K · filed 2023-03-29 | $35.05M 10-K · filed 2021-02-23 | ||||
| 2019-12-31 | -$6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $2.60M derived: sum of 2 quarters · filed 2022-03-04 | $11.52M derived: sum of 3 quarters · filed 2022-03-04 | $20.00M 10-K · filed 2022-03-04 | $35.35M 10-K · filed 2020-02-18 | |
| 2019-09-30 | $8.84M 10-Q · filed 2019-10-31 | $17.76M derived: sum of 2 quarters · filed 2019-10-31 | $26.24M 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $8.92M 10-Q · filed 2019-08-01 | $17.40M 10-Q · filed 2019-08-01 | ||||
| 2019-03-31 | $8.48M 10-Q · filed 2019-05-03 |